Becton, Dickinson and Co. | BDX - Lucro Operacional

Preço das Ações
149.04
Mudança Diária
3.73 2.57%
Mensal
-5.21%
Anual
-12.09%
Q2 Previsão
148.88




Lucro Operacional Alterar Data
Abbott USD 1.85B 399M 2026-03
Agilent USD 353M 90M 2025-12
Align Technology USD 178.05M 46.66M 2026-03
AngioDynamics USD -2.51M 5.41M 2025-09
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Terumo JPY 43.88B 1.21B 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03